Universal Health Services Inc. (UHS): Today's Featured Health Services Laggard

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Universal Health Services ( UHS) pushed the Health Services industry lower today making it today's featured Health Services laggard. The industry as a whole closed the day down 0.3%. By the end of trading, Universal Health Services fell $0.93 (-1.1%) to $79.94 on average volume. Throughout the day, 563,734 shares of Universal Health Services exchanged hands as compared to its average daily volume of 670,400 shares. The stock ranged in price between $79.89-$81.31 after having opened the day at $81.24 as compared to the previous trading day's close of $80.87. Other companies within the Health Services industry that declined today were: Biolase ( BIOL), down 9.3%, ERBA Diagnostics ( ERB), down 8.5%, WuXi PharmaTech (Cayman ( WX), down 8.2% and CAS Medical Systems ( CASM), down 6.5%.

Universal Health Services, Inc., through its subsidiaries, owns and operates acute care hospitals, behavioral health centers, surgical hospitals, ambulatory surgery centers, and radiation oncology centers. Universal Health Services has a market cap of $7.4 billion and is part of the health care sector. Shares are up 0.3% year to date as of the close of trading on Wednesday. Currently there are 9 analysts that rate Universal Health Services a buy, no analysts rate it a sell, and 4 rate it a hold.

TheStreet Ratings rates Universal Health Services as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, impressive record of earnings per share growth, compelling growth in net income, revenue growth and notable return on equity. We feel these strengths outweigh the fact that the company has had generally high debt management risk by most measures that we evaluated.

On the positive front, Navidea Biopharmaceuticals ( NAVB), up 8.1%, SunLink Health Systems ( SSY), up 8.0%, Allied Healthcare Products ( AHPI), up 7.8% and Rosetta Genomics ( ROSG), up 6.6% , were all gainers within the health services industry with Zimmer Holdings ( ZMH) being today's featured health services industry leader.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

If you liked this article you might like

Flu Season May Make Hospital Cash Registers Feel Better ... but Maybe Not

Flu Season May Make Hospital Cash Registers Feel Better ... but Maybe Not

Big Opportunities to Buy Stocks Have Secretly Emerged

Big Opportunities to Buy Stocks Have Secretly Emerged

The Real Story Is Not Tax Reform; It Is Global Demand: Market Recon
The Activist Who Pushed Whole Foods Into the Arms of Amazon Could Target These Companies Next